---
title: "OLD CONVERGENCE PHARMACEUTICALS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0a01ea32-6fc6-5e9b-b735-617f9fffc1cb
json: https://whiteintel.dev/api/public/dossier/0a01ea32-6fc6-5e9b-b735-617f9fffc1cb
identifier: oo:GB-COH-07289568
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# OLD CONVERGENCE PHARMACEUTICALS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-07289568`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0a01ea32-6fc6-5e9b-b735-617f9fffc1cb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0a01ea32-6fc6-5e9b-b735-617f9fffc1cb  

## Ownership & control

### Owners / controllers

- **CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/d279eb68-ed23-5899-9ed8-d9578bd94327
- **CONVERGENCE PHARMACEUTICALS HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d279eb68-ed23-5899-9ed8-d9578bd94327

### UBO chain (walk to the ultimate owner)

A **5-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `07289568`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2010-06-18
- **Registered office:** Building 5 Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UD, England
- **SIC:** 72110

### Officers

- BROMLEY, Kylie Michele — director · Australian · appointed 2022-07-01
- HANBY, Helen Elizabeth — director · British · appointed 2020-02-21
- PURWAHA, Amit Singh — director · British · appointed 2025-07-14
- REYNOLDS, Brenda Elizabeth — secretary · appointed 2010-10-04 · resigned 2015-02-11
- REYNOLDS, Brenda Elizabeth — secretary · British · appointed 2010-08-02 · resigned 2010-10-04
- TATE, Simon — secretary · British · appointed 2010-07-06 · resigned 2010-08-02
- [OLSWANG COSEC LIMITED](https://whiteintel.dev/entity/2518e10d-b1b0-59ca-aa01-99c2ddafab70) — corporate secretary · appointed 2010-06-18 · resigned 2010-07-06
- BINGHAM, Catherine Elizabeth, Dame — director · British · appointed 2010-10-04 · resigned 2014-02-10
- DIX, Clive James — director · British · appointed 2010-07-06 · resigned 2015-02-11
- GREEN, Steven John — director · British · appointed 2018-04-12 · resigned 2020-04-24
- HANDRICH, Alexandra Isabella — director · German · appointed 2020-02-21 · resigned 2022-04-30
- HOLLOWOOD, Christopher, Dr — director · British · appointed 2010-10-04 · resigned 2012-08-31
- MACKIE, Christopher Alan — director · British · appointed 2010-06-18 · resigned 2010-07-06
- MARCHINGTON, Allan Patrick, Dr — director · English · appointed 2012-07-25 · resigned 2014-02-10
- MARTINEZ, Geronimo — director · American · appointed 2023-06-01 · resigned 2025-07-14
- MILL, Trevor Anthony — director · British · appointed 2015-02-11 · resigned 2020-01-31
- MOCHAN, Lori Elizabeth — director · British · appointed 2020-04-21 · resigned 2023-06-01
- RATCLIFFE, Liam Thomas, Dr — director · British · appointed 2010-10-04 · resigned 2014-02-10
- REYNOLDS, Brenda Elizabeth — director · British · appointed 2014-02-10 · resigned 2015-02-11
- REYNOLDS, Brenda Elizabeth — director · British · appointed 2010-08-02 · resigned 2010-10-04

### Beneficial owners (Persons with Significant Control)

- [Convergence Pharmaceuticals Holdings Limited](https://whiteintel.dev/entity/d279eb68-ed23-5899-9ed8-d9578bd94327) — 75–100% shares · corporate PSC · England — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/07289568
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/07289568

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **OLD CONVERGENCE PHARMACEUTICALS LIMITED** — https://whiteintel.dev/entity/0a01ea32-6fc6-5e9b-b735-617f9fffc1cb · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **OLD CONVERGENCE PHARMACEUTICALS LIMITED**. Human view: https://whiteintel.dev/entity/0a01ea32-6fc6-5e9b-b735-617f9fffc1cb · Structured JSON: https://whiteintel.dev/api/public/dossier/0a01ea32-6fc6-5e9b-b735-617f9fffc1cb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._